IPCI
Intellipharmaceuticals International Inc.
IPCI
IPCI
Delisted
IPCI was delisted on the 20th of March, 2019.
24 hedge funds and large institutions have $1.16M invested in Intellipharmaceuticals International Inc. in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
89% less call options, than puts
Call options by funds: $30K | Put options by funds: $281K
Holders
24
Holding in Top 10
–
Calls
$30K
Puts
$281K
Top Buyers
| 1 | +$161K | |
| 2 | +$75.4K | |
| 3 | +$42.8K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$29.7K |
| 5 |
Morgan Stanley
New York
|
+$28.3K |
Top Sellers
| 1 | -$223K | |
| 2 | -$151K | |
| 3 | -$131K | |
| 4 |
HFS
HL Financial Services
Louisville,
Kentucky
|
-$69K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.14K |